Pages tagged "Coalition for Rescheduling Cannabis"
California Medical Association Says U.S. Has “Failed Public Health Policy” on Medical Marijuana, Urges Rescheduling
The first broad marijuana policy statement by a state medical association has become a hot topic of conversation, repeatedly referring to the current federal approach as a “failed public health policy.” Indeed, the October 14, 2011 official policy statement by the California Medical Association (CMA) is gathering significant interest from medical marijuana advocates as well as the broader reform movement. While certain portions of the statement focus on full legalization, the CMA has geared its policy recommendations for those in Washington with the power to reschedule medical marijuana under the Controlled Substances Act (CSA).
The prevailing theme of the CMA policy is that marijuana’s current placement under Schedule I of the CSA has directly and severely hindered researchers from fully establishing marijuana’s medical value. Specifically, the CMA states without equivocation that:
[C]annabis must be moved out of its current Schedule I status.
Notably, the CMA points out that Schedule I classification of cannabis is the principle reason the growing body of international evidence in favor of medical marijuana’s efficacy has been limited in the U.S. to approximately one dozen clinical trials. The CMA ultimately recommends that:
Rescheduling cannabis will allow for further clinical research to determine the utility and risks of cannabis.
By urging the federal government to reclassify marijuana out of Schedule I, the CMA are in effect stating that marijuana does in fact have medical value. While some may choose to play up the reference to “risks,” the CMA was confident enough in medical marijuana’s safety to have issued an August 2011 “Physician Recommendation of Medical Cannabis,” which provides guidance to doctors on how they may treat their sick and dying patients with medical marijuana. In other words, the CMA has asserted that marijuana, even in the absence of FDA approval, is safe enough for physicians to recommend to their patients.
The CMA policy recommendation to reclassify marijuana is one that ASA not only supports, but has also been actively working to implement. As part of the Coalition for Rescheduling Cannabis (CRC), ASA has appealed a July 2011 denial by the DEA of the CRC rescheduling petition. With this policy statement by the CMA, patients and advocates have gained an important champion on the critical issue of federal rescheduling of marijuana. The question now becomes, will Washington officials listen to doctors' orders?
Congressman Steve Cohen (D-TN) wrote a letter to Drug Czar Gil Kerlikowske on Monday, urging a change to the country’s drug policy with regard to marijuana. In addition to calling the federal policy on medical marijuana “misguided,” Cohen said, “Marijuana does not belong on Schedule I of the Controlled Substances Act.”
There is no evidence that marijuana has the same addictive qualities or damaging consequences as these harder drugs and it should not be treated as such.
Cohen, who has taken FBI Director Robert Mueller to task over the federal government’s policy, called for compassion in his letter to Kerlikowske:
We should not deny the thousands of Americans who rely on marijuana to treat the effects of AIDS, cancer, glaucoma, multiple sclerosis, and other illnesses the benefits that marijuana provides.
Cohen also described a personal experience he had with medical marijuana:
I have personally witnessed a close friend who was suffering in the last days of pancreatic cancer benefit tremendously from smoking marijuana. It increased his appetite, eased his pain, and allowed him to smile. It allowed him to deal with death with a little more dignity.
Fortunately, there is a bill currently in Congress that would reclassify medical marijuana. Americans for Safe Access (ASA) is mobilizing people to urge their Members of Congress to pass HR 1983, a bill that would reclassify marijuana to Schedule III and allow states to pass their own laws.
ASA has also taken the Obama Administration to court over its refusal to reclassify marijuana. After a 2002 petition filed by the Coalition for Rescheduling Cannabis (CRC) was denied earlier this year, ASA and the CRC filed an appeal in the D.C. Circuit. Advocates are hopeful that either Congress or the courts will push the federal government to address medical marijuana with a sensible public health policy.
The District of Columbia Circuit issued an order yesterday requiring the Drug Enforcement Administration to answer our petition for writ of mandamus. While this doesn't require the government to actually answer the rescheduling petition filed in 2002 by the Coalition for Rescheduling Cannabis, it is certainly a step in the right direction.